US biotech Equillium’s (Nasdaq EQ) shares fell by 3% to $0.47 after the company announced that the US Food and Drug ...

Gilead Sciences (Nasdaq: GILD) reported flat revenues for the first quarter of 2025, with total sales reaching $6.7 billion, ...

The US Food and Drug Administration (FDA) approved penpulimab-kcqx, from little known Chinese biotech Akeso Biopharma (HKEX: ...

Swiss-American biotech Granite Bio has exited stealth mode with $100 million in funding and plans to advance two experimental ...

Misalignment doesn't usually announce itself. It tends to show up quietly—when teams are making different assumptions, when ...

Dutch biotech Avidicure has launched with $50 million in seed financing to support development of a novel class of ...

US pharma giant Merck & Co was trading nearly 1% lower during Thursday morning’s New York trading, after announcing its first-quarter financial results.

South Korea’s Samsung Bioepis today released its Second Quarter 2025 Biosimilar Market Report, which provides the second ...

Swiss pharma giant Roche (ROG: SIX) today reported that it achieved sales growth of 6% (7% in francs) to 15.4 billion francs ...

Bristol Myers Squibb (NYSE: BMY) beat Wall Street expectations in the first quarter of 2025, sending shares higher in early ...

French pharma major Sanofi delivered a set of first-quarter financial results that seemed to satisfy markets Thursday, as its ...

Zurich-based biotech MetrioPharm has appointed Stephan Rietiker as chair of its board of directors, following a unanimous ...